Ocular Therapeutix, Inc. (NASDAQ:OCUL) Shares Sold by Barclays PLC
Barclays PLC decreased its position in Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) by 35.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 331,242 shares of the biopharmaceutical company’s stock after selling 180,280 shares during the period. Barclays PLC’s holdings in Ocular […]
Barclays PLC decreased its position in Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) by 35.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 331,242 shares of the biopharmaceutical company’s stock after selling 180,280 shares during the period. Barclays PLC’s holdings in Ocular […]
